Haematologica (Feb 2020)

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

  • Massimo Gentile,
  • Giorgina Specchia,
  • Daniele Derudas,
  • Monica Galli,
  • Cirino Botta,
  • Stefano Rocco,
  • Concetta Conticello,
  • Catello Califano,
  • Nicola Giuliani,
  • Silvia Mangiacavalli,
  • Enrico Attingenti,
  • Alessandra Lombardo,
  • Marino Brunori,
  • Elena Rossi,
  • Elisabetta Antonioli,
  • Roberto Ria,
  • Renato Zambello,
  • Nicola Di Renzo,
  • Giuseppe Mele,
  • Gianpaolo Marcacci,
  • Pellegrino Musto,
  • Silvana Capalbo,
  • Nicola Cascavilla,
  • Claudio Cerchione,
  • Angelo Belotti,
  • Clelia Criscuolo,
  • Giuseppina Uccello,
  • Paola Curci,
  • Ernesto Vigna,
  • Vincenzo Fraticelli,
  • Donatella Vincelli,
  • Angela Bonalumi,
  • Agostina Siniscalchi,
  • Raffaella Stocchi,
  • Massimo Martino,
  • Stelvio Ballanti,
  • Dominella Gangemi,
  • Alfredo Gagliardi,
  • Barbara Gamberi,
  • Alessandra Pompa,
  • Anna Grazia Recchia,
  • Giovanni Tripepi,
  • Annalisa Pitino,
  • Ferdinando Frigeri,
  • Ugo Consoli,
  • Sara Bringhen,
  • Elena Zamagni,
  • Francesca Patriarca,
  • Valerio De Stefano,
  • Francesco Di Raimondo,
  • Salvatore Palmieri,
  • Maria Teresa Petrucci,
  • Massimo Offidani,
  • Mario Boccadoro,
  • Michele Cavo,
  • Fortunato Morabito

DOI
https://doi.org/10.3324/haematol.2019.241513
Journal volume & issue
Vol. 106, no. 1

Abstract

Read online

No abstracts available.